Phase III trial (NGR015) with NGR-hTNF plus best investigator choice (BIC) versus placebo plus BIC in previously treated patients with advanced malignant pleural mesothelioma (MPM).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 7501-7501 ◽  
Author(s):  
Rabab M. Gaafar ◽  
Adolfo G. Favaretto ◽  
Vanesa Gregorc ◽  
Francesco Grossi ◽  
Jacek Jassem ◽  
...  
Keyword(s):  
Malignant Pleural Mesothelioma ◽  
Phase Iii ◽  
Pleural Mesothelioma ◽  
Phase Iii Trial ◽  
Previously Treated Patients ◽  
Previously Treated

NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM) .

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 7089-7089 ◽  
Author(s):  
F. De Vincenzo ◽  
G. Rossoni ◽  
A. Santoro ◽  
V. Gregorc ◽  
P. A. Zucali ◽  
...  
Keyword(s):  
Malignant Pleural Mesothelioma ◽  
Pleural Mesothelioma ◽  
Previously Treated Patients ◽  
Previously Treated

scholarly journals Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study

2020 ◽  
Vol 11 (7) ◽  
pp. 1972-1978
Author(s):  
Takaya Ikeda ◽  
Shinnosuke Takemoto ◽  
Hiroaki Senju ◽  
Hiroshi Gyotoku ◽  
Hirokazu Taniguchi ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Study ◽  
Pleural Mesothelioma ◽  
Previously Treated Patients ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document